Interleukin-2-mediated survival and proliferative signals are uncoupled in T lymphocytes that fail to divide after activation

American Journal of Transplantation

Volumn 2, Issue 2, 2002, Pages 120-128

  Kreisel, Daniel ^a   Sankaran, David ^a   Wells, Andrew D ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Cellular proliferation; Cytokines; T lymphocytes

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL DIVISION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES;

EID: 0036487917     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020202.x     Document Type: Article

References (35)

1. Wells AD, Walsh MC, Sankaran D, Turka LA. T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol 2000; 165: 2432-2443.
2. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173-3183.
3. Gudmundsdottir H, Wells AD, Turka LA. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J Immunol 1999; 162: 5212-5223.
4. Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol 2000; 164: 2533-2541.
5. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 1999; 11: 281-288.
6. Ward SG, Westwick J, Hall ND, Sansom DM. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur J Immunol 1993; 23: 2572-2577.
7. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 1997; 94: 3627-3632.
8. Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 1997; 7: 679-689.
9. Craddock BL, Orchiston EA, Hinton HJ, Welham MJ. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling. J Biol Chem 1999; 274: 10633-10640.
10. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 321-241
11. L levels in vivo. J Exp Med 2000; 191: 1721-1734.
12. Pugazhenthi S, Nesterova A, Sable C et al. Akt/protein kinase B upregulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 2000; 275: 10 761-10 766.
13. Wells AD, Li XC, Liy Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307.
14. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 1995; 182: 1973-1983.
15. Strasser A, Harris AW, Corcoran LM, Cory S. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 1994; 368: 457-460.
16. Stambolic V, Suzuki A, de la Pompa JL et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95: 29-39.
17. L. Cell 1996; 87: 619-628.
18. L and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
19. L) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996; 26: 294-299.
20. Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996; 183: 2219-2226.
21. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 1996; 93: 9545-9552.
22. Huang DC, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 1997; 16: 4628-4638.
23. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280: 243-248.
24. Van Parijs L, Biuckians A, Abbas AK. Functional roles of Fas and Bcl2-regulated apoptosis of T lymphocytes. J Immunol 1998; 160: 2065-2071.
25. Van Parijs L, Ibraghimov A, Abbas AK. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996; 4: 321-328.
26. Van Parijs L, Peterson DA, Abbas AK. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998; 8: 265-274.
27. et al. Hallam TA, Chilton DG, Gourley WK et al. Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation. Int Immunol 1997; 9: 945-953.
28. + T cells. J Immunol 2000; 164: 3950-3954.
29. Garcia S, DiSanto J, Stockinger B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 1999; 11: 163-171.
30. Nourse J, Firpo E, Flanagan WM et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372: 570-573.
31. Geginat J, Bossi G, Bender JR, Pardi R. Anchorage dependence of mitogen-induced G1 to S transition in primary T lymphocytes. J Immunol 1999; 162: 5085-5093.
32. Cardone MH, Roy N, Stennicke HR et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321.
33. L interaction and cell survival. J Biol Chem 2000; 275: 25 865-25 869.
34. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NFkappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82-85.
35. + helper T cells. A model for the long-term survival of memory cells. J Immunol 1996; 156: 1764-1771.